×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
中国医学科学院 北... [19]
吉林大学白求恩第一医... [4]
中南大学 [1]
复旦大学上海医学院 [1]
内容类型
期刊论文 [19]
会议论文 [6]
发表日期
2019 [1]
2018 [1]
2017 [5]
2016 [4]
2015 [4]
2014 [2]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共25条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Determination of BPI15086 and its metabolite in human plasma by ultra-high performance liquid chromatography-MS/MS and its application to a pharmacokinetic study
期刊论文
2019, 卷号: 11, 期号: 8, 页码: 773-784
作者:
Wang Shaoyuan
;
Zheng Xin
;
Zhang Yanbao
;
Hu Pei
;
Ding Lieming
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2020/01/03
BPI15086
LC–MS/MS
NSCLC
first-in-human
human plasma
method validation
pharmacokinetics
Efficacy of icotinib in advanced lung squamous cell carcinoma
期刊论文
2018, 卷号: 7, 期号: 9, 页码: 4456-4466
作者:
Liang, Shuai
;
Xu, Yan
;
Tan, Fenlai
;
Ding, Lieming
;
Ma, Yongbin
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2020/01/03
adenocarcinoma
EGFR
EGFR-TKIs
icotinib
squamous cell carcinoma
Simultaneous determination of a novel c-Met/AXL dual-target small-molecule inhibitor BPI-9016M and its metabolites in human plasma by liquid chromatography-tandem mass spectrometry: Application in a pharmacokinetic study in Chinese advanced solid
期刊论文
2017, 卷号: 1068, 页码: 33-40
作者:
Cui, Xinge
;
Zheng, Xin
;
Jiang, Ji
;
Tan, Fenlai
;
Ding, Lieming
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2020/01/03
BPI-9016M
c-Met/AXL dual-target inhibitor
Advanced solid tumor
LC-MS/MS
Human plasma
Chinese
Icotinib as first-line or maintenance therapy in patients with advanced lung adenocarcinoma with positive EGFR mutation and the influence of cytokines shift on survival.
会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2017-05-20
作者:
Sun, Shengjie
;
Jiao, Shun Chang
;
Fang, Jian
;
Sun, Qiong
;
Han, Jindi
收藏
  |  
浏览/下载:8/0
  |  
提交时间:2020/01/04
An updated analysis of ICOGEN to demonstrate utility of a blood-based proteomic test to predict outcomes in EGFR TKI treated patients.
会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2017-05-20
作者:
Shi, Yuankai
;
Han, Xiaohong
;
Zhang, Li
;
Ding, Lieming
;
Dupuis, Nicholas
收藏
  |  
浏览/下载:6/0
  |  
提交时间:2020/01/04
An updated analysis of ICOGEN to demonstrate utility of a blood-based proteomic test to predict outcomes in EGFR TKI treated patients.
期刊论文
2017, 卷号: 35
作者:
Shi, Yuankai
;
Han, Xiaohong
;
Zhang, Li
;
Ding, Lieming
;
Dupuis, Nicholas
收藏
  |  
浏览/下载:8/0
  |  
提交时间:2020/01/04
Icotinib as first-line or maintenance therapy in patients with advanced lung adenocarcinoma with positive EGFR mutation and the influence of cytokines shift on survival.
期刊论文
2017, 卷号: 35
作者:
Sun, Shengjie
;
Jiao, Shun Chang
;
Fang, Jian
;
Sun, Qiong
;
Han, Jindi
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2020/01/04
A retrospective analysis of the ICOGEN clinical trial demonstrates the utility of VeriStrat to predict outcome in an all Chinese cohort treated with EGFR TKI.
期刊论文
2016, 卷号: 34, 期号: 15
作者:
Shi, Yuankai
;
Han, Xiaohong
;
Zhang, Li
;
Ding, Lieming
;
Dupuis, Nicholas
收藏
  |  
浏览/下载:6/0
  |  
提交时间:2020/01/04
First-line icotinib versus cisplatine/pemetrexed plus pemetrexed maintenance therapy in lung adenocarcinoma patients with sensitizing EGFR mutation (CONVINCE).
期刊论文
2016, 卷号: 34, 期号: 15
作者:
Shi, Yuankai
;
Wang, Lin
;
Han, Baohui
;
Li, Wei
;
Yu, Ping
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2020/01/04
A retrospective analysis of the ICOGEN clinical trial demonstrates the utility of VeriStrat to predict outcome in an all Chinese cohort treated with EGFR TKI.
会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2016-05-20
作者:
Shi, Yuankai
;
Han, Xiaohong
;
Zhang, Li
;
Ding, Lieming
;
Dupuis, Nicholas
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2020/01/04
©版权所有 ©2017 CSpace - Powered by
CSpace